Metabolic Stability and Metabolic Profile of Schisandrol B in Rat and Human Liver Microsomes Employing HPLC‐MS/MS Analysis
Rapid Communications in Mass Spectrometry · 15.09.2026 · 40 (17)
DOI: 10.1002/rcm.70127 ↗Kurz gefasst
Fachartikel in der Zeitschrift Rapid Communications in Mass Spectrometry, online erschienen am 18.06.2026. Verfasst von Tao Hu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, The First Affiliated Hospital of Soochow University, Suzhou, China. Hauptthemen laut MEDLINE: Lignans, Microsomes, Liver, Polycyclic Compounds. Die Arbeit nennt 18 Literaturangaben. Gefördert von: Jiangsu Provincial Science and Technology Plan Special Fund, Priority Academic Program Development of the Jiangsu Higher Education Institutes, PAPD.
Abstract (Originalsprache)
Rationale
Schisandrol B (Sol B) is a major bioactive lignan compound extracted from the dried fruits of Schisandra chinensis (Turcz.) Baill. with comprehensive pharmacological activities. The study aims to investigate the metabolic stability and metabolic characteristics of Sol B in rat liver microsomes (RLMs) and human liver microsomes (HLMs) and further clarify the metabolic differences among different species.
Method
The in vitro incubation systems included 5 μM Sol B and 0.5 mg/mL HLMs or RLMs in the presence of NADPH (5 mM) at 37°C in 200 μL phosphate‐buffered saline. The residual amount of Sol B in the incubation system at different time points was determined to calculate the metabolic stability. The main metabolites of Sol B were identified and further elucidated the main metabolic pathways of Sol B.
Results
After incubation in RLMs and HLMs for 60 min, the remaining percentage of parent drug was 26.42% and 55.04%, and the t 1/2 was calculated as 33.6 min and 75.21 min, respectively. A total of seven metabolites were detected in RLMs and HLMs systems. Metabolites M402‐1 and M384‐1 were detected only in the RLMs incubation system, while all other metabolites were monitored in both RLMs and HLMs incubation systems. Main metabolic pathways of Sol B in RLMs and HLMs mainly include dehydration, O‐demethylation, and oxidative dehydrogenation.
Conclusions
The metabolic behavior of Sol B in RLMs and HLMs exhibited certain species differences. Overall, Sol B was more stable in HLMs, with relatively simpler metabolic pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, The First Affiliated Hospital of Soochow University, Suzhou, China.
- College of Pharmaceutical Sciences, Soochow University, Suzhou, China.
- Institute for Interdisciplinary Drug Research and Translational Sciences, Soochow University, Suzhou, China.
ORCID-Profile: Sheng Ma, Liyan Miao
Förderung
- Jiangsu Provincial Science and Technology Plan Special Fund
- Priority Academic Program Development of the Jiangsu Higher Education Institutes, PAPD
Zitieren
APA
Hu, T., Bian, Y., Ma, S., Liu, L., Deng, Q., & Miao, L. (2026). Metabolic Stability and Metabolic Profile of Schisandrol B in Rat and Human Liver Microsomes Employing HPLC‐MS/MS Analysis. Rapid Communications in Mass Spectrometry, 40(17). https://doi.org/10.1002/rcm.70127
Vancouver
Hu T, Bian Y, Ma S, Liu L, Deng Q, Miao L. Metabolic Stability and Metabolic Profile of Schisandrol B in Rat and Human Liver Microsomes Employing HPLC‐MS/MS Analysis. Rapid Communications in Mass Spectrometry. 2026;40(17). doi:10.1002/rcm.70127
BibTeX
@article{Hu2026,
author = {Hu, Tao and Bian, Yicong and Ma, Sheng and Liu, Linsheng and Deng, Qingqing and Miao, Liyan},
title = {Metabolic Stability and Metabolic Profile of Schisandrol B in Rat and Human Liver Microsomes Employing HPLC‐MS/MS Analysis},
journal = {Rapid Communications in Mass Spectrometry},
year = {2026},
volume = {40},
number = {17},
doi = {10.1002/rcm.70127}
}
EUVIMED